santa cruz biotechnology, inc.
SCBT Logo

Willkommen!        Produkt(e) im Warenkorb.     Bestellen
 

Potassium Channel Modulators

  • 1-EBIO
    Activates epithelial K/Ca channels; stimulates a large and sustained trans-epithelial Cl- secretory response across T84 monolayers. Induces hyperpolarization in aortic value endothelial cells.
    Katalog #CAS NummerSummenformelMenge
    sc-20169510045-45-1C9H10N2O10 mg/50 mg
  • (-)-[3R,4S]-Chromanol 293B
    Katalog #CAS NummerSummenformelMenge
    sc-361081163163-24-4C15H20N2O4S10 mg/50 mg
  • 5-(4-Phenoxybutoxy)psoralen
    Selective inhibitor of Kv1.3, voltage-gated potassium channel. PAP-1 (EC50=2 nM) potently inhibits human T effector memory cell proliferation and delayed hypersensitivity. Effective orally or intraperitoneally. 5-(4-Phenoxybutoxy)psoralen has 23-fold selectivity for Kv1.3 over Kv1.5, and 33-125-fold selectivity over other Kv1 family channels.
    Katalog #CAS NummerSummenformelMenge
    sc-252247870653-45-5C21H18O55 mg
  • 5-Hydroxydecanoate Na
    A substrate for mitochondrial outer membrane acyl-CoA synthetase that inhibits ATP-sensitive K+ channels.
    Katalog #CAS NummerSummenformelMenge
    sc-200992624-00-0C10H19O3 ·Na100 mg/500 mg
  • Adenosine 5'-O-(3-thiotriphosphate), tetralithium salt
    An unhydrolyzable analogue of ATP which acts as an agonist for P2X2-R, activating calcium channels causing an influx of Ca2+ inside the cell.
    Katalog #CAS NummerSummenformelMenge
    sc-20203993839-89-5C10H12N5O12P3S ·4Li1 mg/5 mg
  • Adenosine 5'-Triphosphate, disodium salt
    A p2 purinergicagonist, increases activity of Ca2+ activated K+ channels. Induces a dose-dependant release of histamine and prostaglandin D2 from rat peritoneal mast cells.
    Katalog #CAS NummerSummenformelMenge
    sc-202040987-65-5C10H14N5O13P3 ·2Na1 g/5 g
  • Adenylyl-imidodiphosphate, Tetralithium Salt
    A non-hydrolyzable ATP analog that acts as a competitive inhibitor of ATP-dependent enzyme systems. Known to block ATP-sensitive Ca2+ activated K+ channels.
    Katalog #CAS NummerSummenformelMenge
    sc-20380572957-42-7C10H15N6O13P3 ·4Li25 mg
  • Alinidine
    Alinidine is an HCN Channel blocker of neuronal Ih, related cardiac If channels and ATP-sensitive Kir channels. It is an analog of clonidine; bradycardic and antiarrhythmic agent (sinus tachyarrhythmias). Alinidine affects physiological markers in conscious dogs. Alinidine in four intravenous (i.v.) injections of 0.5, 0.5, 1, and 2 mg/kg, decreased sinus rate (< or = 43%) and ventricular rate (< or = 44%), but increased atrial rate (< or = 31%). It lengthened CSRT (< or = 71%) at the two highest doses and increased AERP (< or = 33%) and decreased WP (< or = 33%) at all doses. Alinidine did not modify mean blood pressure at any dose in either group. These results indicate that alinidine exhibits electrophysiologic effects in conscious dogs that reflect the marked antiarrhythmic potential of this agent, apart from its assumed antiischemic properties.
    Katalog #CAS NummerSummenformelMenge
    sc-25235733178-86-8C12H13Cl2N310 mg
  • α-Dendrotoxin
    A compound originally isolated from Dendroaspis angusticeps that has been shown to mediate voltage-gated-K+ channels.
    Katalog #CAS NummerSummenformelMenge
    sc-25233374504-53-3n.n..1 mg
  • AM 92016 hydrochloride
    A specific blocker of the time dependent delayed rectifier potassium current, devoid of any β-adrenoceptor blocking activity. Exhibits prohypertensive and proarrhythmic activity in vivo.
    Katalog #CAS NummerSummenformelMenge
    sc-203506178894-81-0C19H24Cl2N2O4S•HCl•xH2O10 mg/50 mg
  • Apamin
    Caution! Highly toxic. Handle with care. Apamin is a potent (1-10 nM) and highly selective inhibitor of the low conductance Ca2+-activated K+ channel.
    Katalog #CAS NummerSummenformelMenge
    sc-20099424345-16-2C79H131N31O24S4500 µg/1 mg
  • Aprindine hydrochloride
    Aprindine hydrochloride is a class Ib antiarrhythmic and hERG channel blocker. Aprindine shows structure similarities to lidocaine and procainamide and is effective in treatment of patients with ventricular premature depolarizations, ventricular tachycardia, and supraventricular arrhythmias. Aprindine inhibits the activation of bovine brain cyclic 3':5'-nucleotide phosphodiesterase (EC 3.1.4.17) by calmodulin and inhibits calmodulin-stimulated Ca-ATPase (ATP phosphohydrolase EC 3.6.1.3) activity.
    Katalog #CAS NummerSummenformelMenge
    sc-25238333237-74-0C22H30N2•HCl10 mg
  • BL-1249
    Putative activator of potassium TREK-1 channel
    Katalog #CAS NummerSummenformelMenge
    sc-25249818200-13-0C17H17N510 mg
  • BMS 191011
    Opener of the cloned large-conductance, Ca2+-activated potassium (maxi-K) channel. Neuroprotectant in two distinct animal models of stroke (MCAO in the SHR rat and a normotensive model of focal stroke).
    Katalog #CAS NummerSummenformelMenge
    sc-203847202821-81-6C16H10ClF3N3O310 mg/50 mg
  • Charybdotoxin
    A potent and selective inhibitor of the large conductance Ca2+ -activated K+ channels.
    Katalog #CAS NummerSummenformelMenge
    sc-20097995751-30-7C176H289N57O56S7100 µg
  • Chromanol 293B
    Blocker of the slow delayed rectifier K+ current via KCNQ1 channels. Also blocks CFTR chloride current.
    Katalog #CAS NummerSummenformelMenge
    sc-203889163163-23-3C15H20N2O4S10 mg/50 mg
  • Clofilium tosylate
    A quaternary ammonium compound that acts as potassium channel blocker.
    Katalog #CAS NummerSummenformelMenge
    sc-20300192953-10-1C21H37ClN•C7H7O3S25 mg/100 mg
  • CP 339818 hydrochloride
    Non-peptide, inhibits Kv1.3 in a use-dependent manner by preferentially blocking the C-type inactivated state of the channel. Appears to recognize only the inactivated conformation of Kv1.3
    Katalog #CAS NummerSummenformelMenge
    sc-203903185855-91-8C21H24N2 ·HCl10 mg/50 mg
  • CP-339818
    Blocks both Kv1.3 and Kv1.4. Kv1.3 is expressed in the brain and in effector memory Tem (T) cells, and Kv1.4 is expressed in brain cells. Kv1.3 and Kv1.4 are members of the Shaker family of voltage-gated potassium channels. Both channels are involved in setting the membrane potential of neurons. Kv1.3 also maintains the membrane potential for T memory cells and is up-regulated upon T cell activation, contributing to multiple immune processes and disorders. Blockers of Kv1.3 have long been sought for therapeutic benefit, and they are also valuable tools for studying the immune system. CP-339818 is valuable for immune system studies, where the absence of Kv1.4 makes it functionally selective for Kv1.3, and it has shown suppression of T cell activation. CP-339818 is also valuable for the study of Kv1.4 function.
    Katalog #CAS NummerSummenformelMenge
    sc-252641478341-55-8C21H24N2•HCl5 mg
  • (+/-)-Cromakalim
    Katalog #CAS NummerSummenformelMenge
    sc-21795894470-67-4C16H18N2O325 mg
  • CyPPA
    CyPPA is an activator of small conductance Ca2+-activated K+ channels. Selective for SK2 and SK3 channels, no selectivity for SK1 and IK channels.
    Katalog #CAS NummerSummenformelMenge
    sc-20528173029-73-9C16H23N510/50 mg
  • Dequalinium chloride hydrate
    A selective blocker of apamin-sensitive K+ channels.
    Katalog #CAS NummerSummenformelMenge
    sc-214869522-51-0 (anhydrous)C30H40Cl2N4•xH2O5 g
  • Diazoxide
    A benzothiadiazine derivative which functions as a selective ATP-dependent K+ channel activator and calcium channel blocker.
    Katalog #CAS NummerSummenformelMenge
    sc-200980364-98-7C8H7ClN2O2S1 g
  • DMP 543
    Potent neurotransmitter release enhancer, K+ channel blocker, and acetylcholine release stimulator. Potential Alzheimer’s disease therapeutic.
    Katalog #CAS NummerSummenformelMenge
    sc-203926160588-45-4C26H18F2N2O10 mg/50 mg
  • DPO-1
    Blocker of Kv1.5 channel and IKur ultrarapid delayed rectifier potassium current. (IC50 = 0.31 μM for rKV1.5). Displays selectivity for inhibition of IKur over Ito (8-fold), IK1, IKr and IKs (20-fold) in native myocytes and selectivity for rat recombinant KV1.5 over KV3.1 (~ 15-fold). Increases action potential duration in atrial but not ventricular myocytes and prevents atrial arrhythmia.
    Katalog #CAS NummerSummenformelMenge
    sc-20357043077-30-1C22H29OP10 mg/50 mg
  • E-4031 dihydrochloride
    K+ channel blocker. Blocks the human ether-a-go-go-related gene (HERG) at all pulse frequencies without significant rest.
    Katalog #CAS NummerSummenformelMenge
    sc-203034113559-13-0C21H27N3O3S ·2HCl ·2H2O5 mg
  • Gabapentin-lactam
    Demonstrates a neuroprotective capacities via opening of ATP-sensitive potassium channels. Also shown to reduce oxygen glucose deprivation-induced [3H]glutamate release in vivo.
    Katalog #CAS NummerSummenformelMenge
    sc-20100364744-50-9C9H15NO50 mg/250 mg
  • Gliclazide
    Sulfonylurea hypoglycemic agent used as an antidiabetic.
    Katalog #CAS NummerSummenformelMenge
    sc-21156121187-98-4C15H21N3O3S1 g
  • Glyburide (Glibenclamide)
    A sulfonylurea compound shown to bind to ATP-dependent K+channels. Stimulates insulin release in pancreatic beta cells.
    Katalog #CAS NummerSummenformelMenge
    sc-20098210238-21-8C23H28ClN3O5S1 g/5 g
  • GW 542573X
    Katalog #CAS NummerSummenformelMenge
    sc-362741660846-41-3C19H28N2O510 mg/50 mg
  • ICA 069673
    Katalog #CAS NummerSummenformelMenge
    sc-362745582323-16-8C11H6ClF2N3O10 mg/50 mg
  • Isopimaric Acid
    Potently opens large conductance Ca-activated K+ channels.
    Katalog #CAS NummerSummenformelMenge
    sc-2692705835-26-7C20H30O25 mg
  • Kaliotoxin
    Katalog #CAS NummerSummenformelMenge
    sc-362754145199-73-1C171H283N55O49S810 µg
  • L-364,373
    Activator of KCNQ1 (KVLQT1) channels; activates the cardiac IKs current that decreases action potential duration (APD) in cardiac myocytes.
    Katalog #CAS NummerSummenformelMenge
    sc-204036103342-82-1C25H20FN3O10 mg/50 mg
  • Levcromakalim
    Katalog #CAS NummerSummenformelMenge
    sc-36123094535-50-9C16H18N2O310 mg/50 mg
  • Linopirdine dihydrochloride
    Blocker of KCNQ voltage-gated potassium channels; blocks KCNQ2+3/M-currents (IC50 = 4-7 μM) and KCNQ1 homomeric channels (IC50 = 8.9 μM). Increases hippocampal ACh release and is a cognitive enhancer following oral administration in vivo.
    Katalog #CAS NummerSummenformelMenge
    sc-204058105431-72-9C26H21N3O ·2HCl10 mg/50 mg
  • Margatoxin, Recombinant
    Katalog #CAS NummerSummenformelMenge
    sc-358754145808-47-5C178H286N52O50S710 µg
  • Minoxidil (U-10858)
    A selective ATP dependent vasodilator and K+ channel activator. Activates the β-catenin pathway in human dermal papilla cells.
    Katalog #CAS NummerSummenformelMenge
    sc-20098438304-91-5C9H15N5O100 mg/500 mg
  • Minoxidil sulfate (U-58838)
    A K+ channel agonist and a strong vascular smooth muscle relaxant. It can relax norepinephrine contraction, and is reported to be a vasodilator.
    Katalog #CAS NummerSummenformelMenge
    sc-20098783701-22-8C9H15N5O4S5 mg/25 mg
  • Mitiglinide Calcium
    Thought to stimulate insulin secretion by closing the ATP-sensitive K(+) K(ATP) channels in pancreatic beta-cells.
    Katalog #CAS NummerSummenformelMenge
    sc-204808145375-43-5(C19H24NO3)2 ·• Ca100 mg/250 mg
  • N-Salicyloyltryptamine
    An activator of calcium-activated K+ channels which acts as an anticonvulsant and neuroprotectant.
    Katalog #CAS NummerSummenformelMenge
    sc-25312431384-98-2C17H16N2O25 mg
  • Nicorandil
    A K(ATP) channel opener. Stimulates guanylyl cyclase and increases cyclic GMP levels. Upregulates eNOS expression. NO donor.
    Katalog #CAS NummerSummenformelMenge
    sc-20099565141-46-0C8H9N3O450 mg
  • NS 1643
    hERG K+ channel activator. Displays different molecular mechanisms of action at hERG1 and hERG2 channels. Exhibits antiarrhythmic activity in vitro.
    Katalog #CAS NummerSummenformelMenge
    sc-204135448895-37-2C15H10F6N2O310 mg/50 mg
  • NS 5806
    Katalog #CAS NummerSummenformelMenge
    sc-362773426834-69-7C16H8Br2F6N6O10 mg/50 mg
  • NS-1619
    A selective large conductance calcium activated potassium channel activator.
    Katalog #CAS NummerSummenformelMenge
    sc-200986153587-01-0C15H8F6N2O25 mg
  • NS8593 hydrochloride
    Katalog #CAS NummerSummenformelMenge
    sc-253203875755-24-1C17H17N3•HCl5 mg
  • P1075
    Potent KATP channel opener (EC50 for relaxation of rat aorta = 7.5 nM). Binds to SUR2A and SUR2B with high affinity (Kd values are 17 and 3 nM respectively).
    Katalog #CAS NummerSummenformelMenge
    sc-20365760559-98-0C12H17N510 mg/50 mg
  • Paxilline
    An indole alkaloid which selectively and reversibly blocks the high conductance Ca2+-activated K+ channel; enhances binding of Charybdotoxin to maxi-K channels.
    Katalog #CAS NummerSummenformelMenge
    sc-358857186-25-1C27H33NO45 mg/25 mg
  • Paxillinol
    A negative control for the maxi-K channel inhibitor paxilline (50% block at 0.1-1 µM)1.
    Katalog #CAS NummerSummenformelMenge
    sc-205792n.n.C27H35NO42 mg
  • PCO 400
    This product is an analog of comakalim and a selective and potent ATP-sensitive K+ channel opener.
    Katalog #CAS NummerSummenformelMenge
    sc-200989121055-10-5C17H17NO420 mg/100 mg
  • PD-118057
    An activator of ether-a-go-go-related (hERG) potassium channel. It is a second identified hERG channel activator, a representative in the series of structural analogs; PD-118057 at 10 µM leads to a 111% current increase in rabbit ventricular wedge (in comparison RPR260243 leads to only a 15% increase at the same concentration). PD-118057, unlike RPR260243, does not have a major effect on gating or kinetic properties of this channel. This chemical prevents and reverses QT interval prolongation. Compounds such as PD-118057 may offer a new approach in the treatment of delayed repolarization conditions, which occur in inherited or acquired long QT syndrome and congestive heart failure.
    Katalog #CAS NummerSummenformelMenge
    sc-253238313674-97-4C21H17Cl2NO25 mg
  • Penitrem A
    A potent neurotoxin that has been shown to have numerous effects on ion channels and neurotransmitter release. Can also induce an increase in the voltage and frequency of cerebral cortex electrical activity.
    Katalog #CAS NummerSummenformelMenge
    sc-20099712627-35-9C37H44ClNO61 mg/5 mg
  • Pinacidil
    An opener of K+ channels. Induces relaxation of serotonin-produced contractions of arterial tissue through opening of ATP-dependent K+ channels.
    Katalog #CAS NummerSummenformelMenge
    sc-20319885371-64-8C13H19N5 ·H2O10 mg/50 mg
  • Potassium dicyanoargentate
    Dicyanoargentate ion is a versatile bridging ligand that has application for constructing multidimensional polymers.
    Katalog #CAS NummerSummenformelMenge
    sc-253300506-61-6C2AgKN210 g
  • Psora-4
    The lymphocyte potassium channel Kv1.3 is a new target for immunosuppression. This is the most potent small-molecule Kv1.3 blocker known. It blocked Kv1.3 in a use-dependent manner, with a Hill coefficient of 2 and an EC50 value of 3 nM, by preferentially binding to the C-type inactivated state of the channel. It exhibited 17- to 70-fold selectivity for Kv1.3 over closely related Kv1-family channels (Kv1.1, Kv1.2, Kv1.4, and Kv1.7) with the exception of Kv1.5 (EC50, 7.7 nM) and showed no effect on human ether-a-go-go-related channel, Kv3.1, the calcium-activated K+ channels (IKCa1, SK1-SK3, and BKCa), or the neuronal NaV1.2 channel. In a test of in vivo toxicity in rats, Psora-4 did not display any signs of acute toxicity after five daily subcutaneous injections at 33 mg/kg body weight. Psora-4 selectively suppressed the proliferation of human and rat myelin-specific effector memory T cells with EC50 values of 25 and 60 nM, respectively, without persistently suppressing peripheral blood naive and central memory T cells. Because autoantigen-specific effector memory T cells contribute to the pathogenesis of T cell-mediated autoimmune diseases such as multiple sclerosis, Psora-4 and other Kv1.3 blockers may be useful as immunomodulators for the therapy of autoimmune disorder.
    Katalog #CAS NummerSummenformelMenge
    sc-253325724709-68-6C21H18O45 mg
  • Quinine hemisulfate
    Stereoisomer of quinidine. Plant alkaloid with a broad spectrum of biological effects including anti-cholinergic, hypoglycemic and antimalarial properties. K+ channel blocker.
    Katalog #CAS NummerSummenformelMenge
    sc-2023056119-70-6C20H24N2O2 ·0.5H2SO410 g
  • Quinine hydrochloride dihydrate
    Potassium channel blocker
    Katalog #CAS NummerSummenformelMenge
    sc-2126196119-47-7C20H24N2O2•HCl•2H2O5 g/25 g
  • R-(+)-DIOA
    Inhibitor of the K+/Cl--cotransport that does not affect the bumetanide-sensitive Na+/K+/Cl--cotransport system
    Katalog #CAS NummerSummenformelMenge
    sc-20323081166-47-4C20H24Cl2O45 mg/25 mg
  • Retigabine Dihydrochloride
    A KCNQ/Kv7 potassium channel activator which functions by enhancing potassium currents via stabilizing the open conformation of the Kv7.2-7.3 channels.
    Katalog #CAS NummerSummenformelMenge
    sc-212772150812-13-8C16H18FN3O2•2HCl10 mg
  • Sematilide monohydrochloride monohydrate
    A class III antiarrhythmic compound showing selective delayed rectifier K+ current channel blocking. It has been shown to inhibit rapidly activating lk in atrial myocytes in guinea pigs. This results in the prolongation of AP duration and refractor capacity. Has exhibited proarrhythmic effects, potentailly leading to QT interval prolongation.
    Katalog #CAS NummerSummenformelMenge
    sc-253550101526-62-9 (non-salt)C14H23N3O3S··HCl•H2O50 mg
  • SG 209
    K+ channel opener. Nitrate-free coronary vasodilator, analog of nicorandil.
    Katalog #CAS NummerSummenformelMenge
    sc-20427683440-03-3C10H12N2O310 mg/50 mg
  • Tertiapin LQ
    Katalog #CAS NummerSummenformelMenge
    sc-362807n.n.C106H179N33O24S41 mg
  • Tetracaine hydrochloride
    A topical ophthalmic anesthetic which is used for spinal anesthesia Blocks voltage-sensitive release of Ca(2+) from sarcoplasmic reticulum.
    Katalog #CAS NummerSummenformelMenge
    sc-251166136-47-0C15H24N2O2•HCl5 g/25 g
  • Tolbutamide
    An agonist for secretion of islet hormones somatostatin, insulin and glucagon and for proliferation beta-cells in the presence of calcium in hypoglycemic conditions.
    Katalog #CAS NummerSummenformelMenge
    sc-20329864-77-7C12H18N2O3S5 g
  • Tolfenamic Acid
    Non steroidal anti-inflammatory agent found to inhibit COX-2 isoenzymes in dogs. Its analgesic property is due to activation of Ca2+ -activated K+ channels.
    Katalog #CAS NummerSummenformelMenge
    sc-20491813710-19-5C14H12ClNO25 g/25 g
  • TRAM-34
    Shown to inhibit IK1 channels in human T lymphocytes. This inhibition has been reported to modulate cell proliferation in a concentration dependent manner.
    Katalog #CAS NummerSummenformelMenge
    sc-201005289905-88-0C22H17ClN25 mg/25 mg
  • U-37883A
    U-37883A is a potent inhibitor of vascular smooth muscle K-ATP channels.
    Katalog #CAS NummerSummenformelMenge
    sc-20100157568-80-6C21H35N3O··HCl5 mg/25 mg
  • UCL 1684
    Katalog #CAS NummerSummenformelMenge
    sc-361390199934-16-2C34H30N4•2Br5 mg
  • UCL 1684 ditrifluoroacetate hydrate
    A potent, non-peptide blocker of the apamin-sensitive Ca2+-activated K+ channel.
    Katalog #CAS NummerSummenformelMenge
    sc-253818201147-19-5 (anhydrous)(C34H30N4)2+•(C2F3O2-)2•xH2O5 mg
  • UCL 2077
    Slow afterhyperpolarization (sAHP) channel blocker that reduces sAHP in hippocampal slice preparations. Displays no effect on the time course of sAHP/sIAHP or Ca2+ currents.
    Katalog #CAS NummerSummenformelMenge
    sc-204371918311-87-2C25H22N210 mg/50 mg
  • UCL-1848 trifluoroacetate salt
    A selective, Ca2+-activated, SK potassium channel blocker.
    Katalog #CAS NummerSummenformelMenge
    sc-253819201147-53-7C32H34F6N4O4•xC2HF3O25 mg
  • UK 78282 hydrochloride
    Katalog #CAS NummerSummenformelMenge
    sc-361395136647-02-4C29H35NO2.HCl10 mg/50 mg
  • UK-78282 monohydrochloride
    UK-78282 blocks Kv1.3 and Kv1.4, which are members of the Shaker family of voltage-gated potassium channels. Kv1.3 is expressed in brain and effector memory T (Tem) cells, and Kv1.4 is expressed in brain. Both channels are involved in setting the membrane potential of neurons. Kv1.3 also maintains the membrane potential for T memory cells and is up-regulated upon T cell activation, contributing to multiple immune processes and disorders. Blockers of Kv1.3 have long been sought for therapeutic benefit, and they are also valuable tools for studying the immune system. Selective blockers of Kv1.4 are desired, as there are few if any currently available. UK-78282 is valuable for immune system studies, where the absence of Kv1.4 makes it functionally selective for Kv1.3, and it has shown suppression of T cell activation. UK-78282 is also valuable for the study of Kv1.4 function.
    Katalog #CAS NummerSummenformelMenge
    sc-253820136647-02-4C29H35NO2 ·HCl5 mg
  • Verruculogen
    Neurotoxin that inhibits the M phase of the mammalian cell cycle. Inhibits Ca2+ -activated K+ channels. Decreases GABA levels in CNS.
    Katalog #CAS NummerSummenformelMenge
    sc-20493912771-72-1C27H33N3O71 mg/5 mg
  • XE 991 dihydrochloride
    Potent and selective blocker of KCNQ voltage-gated potassium channels. Blocks KCNQ2+3/M-currents and KCNQ1 homomeric channels but is less potent against KCNQ1/minK channels.
    Katalog #CAS NummerSummenformelMenge
    sc-203453122955-42-4C26H20N2O ·2HCl10 mg/50 mg
  • Y-26763
    KATP channel opener and active metabolite of Y-27152. In vitro, causes relaxation of contracted rat aortic rings (IC50 = 0.027 mM) and inhibits glucose-induced insulin secretion in isolated human pancreatic b-cells. In vivo, produces hypotension in spontaneously hypertensive rats and shows cardioprotective properties in dogs following systemic administration.
    Katalog #CAS NummerSummenformelMenge
    sc-204406127408-31-5C14H16N2O410 mg/50 mg
  • Y-27152
    Prodrug of the KATP channel opener Y-26763. Inactive in vitro; fails to modify tension in contracted aortic rings at concentrations up to 1 mM. Orally active in vivo, produces long-lasting antihypertensive effects with minimal tachycardia following oral administration in hypertensive animals.
    Katalog #CAS NummerSummenformelMenge
    sc-204407127408-30-4C21H22N2O410 mg/50 mg
  • YS-035 hydrochloride
    Ca2+ blocker that prolongs cardiac action potentials through inhibition of pacemaker current and outward K+ currents.
    Katalog #CAS NummerSummenformelMenge
    sc-20372233978-72-2C21H29NO4 ·HCl10 mg/50 mg
  • ZM 226600
    A selective KATP channel opener.
    Katalog #CAS NummerSummenformelMenge
    sc-281189147695-92-9C16H14F3NO4S10 mg/50 mg